1228639-16-4

Basic information

• Product Name: N-[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]-8-phenyloctanamide
• Synonyms: N-[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]-8-phenyloctanamide
• CAS NO: 1228639-16-4
• Molecular Weight: 357.58
• Mol File: 1228639-16-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]-8-phenyloctanamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]-8-phenyloctanamide(1228639-16-4)
• EPA Substance Registry System: N-[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]-8-phenyloctanamide(1228639-16-4)

Safety Data

• Hazardous Substances Data: 1228639-16-4(Hazardous Substances Data)

Upstream product

• 26547-51-3 8-phenyloctanoic acid 
• 34048-57-2 (-)-(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexaneammonium chloride 

Relevant articles and documents

(-)-Menthylamine derivatives as potent and selective antagonists of transient receptor potential melastatin type-8 (TRPM8) channels

A series of twenty-two (-)-menthylamine derivatives was synthesized and tested on TRPM8, TRPV1, and TRPA1 channels. Five of the novel compounds, that is, 1d, 1f, 2b, 2c, and 2e behaved as potent TRPM8 antagonists with IC50 values versus icilin and (-)-menthol between 20 nM and 0.7 μM, and were between 4- and ～150-fold selective versus TRPV1 and TRPA1 activation. Compound 1d also induced caspase 3/7 release in TRPM8-expressing LNCaP prostate carcinoma cells, but not in non-TRPM8 expressing DU-145 cells. Five other derivatives, that is, 1a, 1g, 1h, 2f, and 2h were slightly less potent than previous compounds but still relatively selective versus TRPV1 and TRPA1.